Abstract:Background: Despite much work, safe and effective approaches to attack and deplete the long-lived reservoir of cells latently infected with HIV-1 remain an elusive goal. Patients infected with HIV-1 treated with cytotoxic agents or bone marrow transplantation can experience decreases in the reservoir of HIV-1 latently infected cells. Other viruses capable of long-term latency, such as herpesviruses, can sense host cell apoptosis and respond by initiating replication. These observations suggest that other viruses capable of long-term latency, like HIV-1, might also sense when its host cell is about to undergo apoptosis and respond by initiating replication. Results: Pro-monocytic (U1) and lymphoid (ACH-2) HIV-1 persistently infected cell lines were treated with cytotoxic drugs - doxorubicin, etoposide, fludarabine phosphate, or vincristine - and activation of latent HIV-1 was evaluated using assays for HIV-1 RNA and p24 production. Both cell lines showed dose-dependent increases in apoptosis and associated HIV-1 activation following exposure to the cytotoxic agents. Pretreatment of the cells with the pan-caspase inhibitor Z-VAD-FMK prior to exposure to the cytotoxic agents inhibited apoptosis and viral activation. Direct exposure of the latently infected cell lines to activated caspases also induced viral replication. HIV-1 virions produced in association with host cell apoptosis were infectious. Conclusions: The results indicate that latent HIV-1 can sense when its host cell is undergoing apoptosis and responds by completing its replication cycle. The results may help explain why patients treated with cytotoxic regimens for bone marrow transplantation showed reductions in the reservoir of latently infected cells. The results also suggest that the mechanisms that HIV-1 uses to sense and respond to host cell apoptosis signals may represent helpful new targets for approaches to attack and deplete the long-lived reservoir of cells latently infected with HIV-1.

Some mechanisms of FLIP expression in inhibition of HIV-1 replication in Jurkat cells, CD4+ T cells and PBMCs

Killing HIV-infected Resting Central Memory CD4+ T Cells by Targeting Inhibitor of Apoptosis Proteins-Inhibited Autophagy

Tat-induced FOXO3a is a key mediator of apoptosis in HIV-1-infected human CD4+ T lymphocytes

c-FLIP facilitates ZIKV infection by mediating caspase-8/3-dependent apoptosis

[Relationship Between High Expression of C-Flip and Drug Resistance of Leukemia Cells].

Apoptosis-induced activation of HIV-1 in latently infected cell lines

Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection

The communication disorder in dialysis dementia: A case report

Nuclear Localization of C-Flip-l and Its Regulation of AP-1 Activity

Transgenic Expression of the Viral FLIP MC159 Causes Lpr/gld-Like Lymphoproliferation and Autoimmunity

Inhibition of caspase pathways limits CD4+ T cell loss and restores host anti-retroviral function in HIV-1 infected humanized mice with augmented lymphoid tissue

The Inhibition of Gag-Pol Expression by the Restriction Factor Shiftless Is Dispensable for the Restriction of HIV-1 Infection

MCPIP1 Restricts HIV Infection and is Rapidly Degraded in Activated CD4+ T Cells

Predictive assessment of surface resistances in zeolite membranes using atomically detailed models.

FBXO34 Promotes Latent HIV-1 Activation by Post-Transcriptional Modulation

The Identification of New c-FLIP Inhibitors for Restoring Apoptosis in TRAIL-Resistant Cancer Cells

PD-L1 Expression on Retrovirus-Infected Cells Mediates Immune Escape from CD8+ T Cell Killing

Noncompliance May Render Migraine Prophylaxis Useless, But Once-Daily Regimens Are Better

Inhibition of the lncRNA SAF drives activation of apoptotic effector caspases in HIV-1–infected human macrophages

The effects of MAPK p38α on AZT resistance against reactivating HIV-1 replication in ACH2 cells

Selective cell death in HIV-1-infected cells by DDX3 inhibitors leads to depletion of the inducible reservoir